KRIYATHERAPEUTICS.COM: Keyword Density Checker

Total words: 1172 | 2-word phrases: 304 | 3-word phrases: 327 | 4-word phrases: 334

PAGE INFO

Title	Try to keep the title under 60 characters (42 characters) Kriya Therapeutics: Gene Therapy Redefined
Description	Try to keep the meta description between 50 - 160 characters (90 characters) Kriya is a biopharmaceutical company developing gene therapies to address common diseases.
Keywords	Meta keywords are not recommended anymore (0 characters)
H1	H1 tag on the page (24 characters) Gene Therapy. Redefined.

#	Keyword	Frequency	Density
1	8 2024 kriya	2	0.61%
2	as chief legal	2	0.61%
3	in vision and	2	0.61%
4	research in vision	2	0.61%
5	association for research	2	0.61%
6	2024 association for	2	0.61%
7	the 2024 association	2	0.61%
8	at the 2024	2	0.61%
9	kriya announces three	2	0.61%
10	chief legal officer	2	0.61%
11	eade as chief	2	0.61%
12	millions of people	2	0.61%
13	katherine eade as	2	0.61%
14	officer kriya appoints	2	0.61%
15	gene therapy officer	2	0.61%
16	chief gene therapy	2	0.61%
17	wright phd as	2	0.61%
18	fraser wright phd	2	0.61%
19	scientific cofounder j	2	0.61%
20	appoints scientific cofounder	2	0.61%
21	kriya appoints scientific	2	0.61%
22	palo alto ca	2	0.61%
23	for research in	2	0.61%
24	disease targets trigeminal	1	0.31%
25	in palo alto	1	0.31%
26	eye disease undisclosed	1	0.31%
27	thyroid eye disease	1	0.31%
28	atrophy thyroid eye	1	0.31%
29	disease targets geographic	1	0.31%
30	gene therapy and	1	0.31%

#	Keyword	Frequency	Density
1	eade as chief legal	2	0.60%
2	appoints scientific cofounder j	2	0.60%
3	as chief legal officer	2	0.60%
4	chief gene therapy officer	2	0.60%
5	at the 2024 association	2	0.60%
6	the 2024 association for	2	0.60%
7	2024 association for research	2	0.60%
8	association for research in	2	0.60%
9	katherine eade as chief	2	0.60%
10	research in vision and	2	0.60%
11	fraser wright phd as	2	0.60%
12	for research in vision	2	0.60%
13	kriya appoints scientific cofounder	2	0.60%
14	complex biologics we are	1	0.30%
15	located in palo alto	1	0.30%
16	undisclosed neurology neurology icon	1	0.30%
17	disease targets trigeminal neuralgia	1	0.30%
18	targets trigeminal neuralgia focal	1	0.30%
19	trigeminal neuralgia focal epilepsy	1	0.30%
20	neuralgia focal epilepsy undisclosed	1	0.30%
21	focal epilepsy undisclosed read	1	0.30%
22	more kriya is led	1	0.30%
23	kriya is led by	1	0.30%
24	is led by a	1	0.30%
25	led by a team	1	0.30%
26	by a team of	1	0.30%
27	pioneers in the fields	1	0.30%
28	a team of exceptional	1	0.30%
29	and complex biologics we	1	0.30%
30	therapy and complex biologics	1	0.30%
31	gene therapy and complex	1	0.30%
32	of gene therapy and	1	0.30%
33	fields of gene therapy	1	0.30%
34	the fields of gene	1	0.30%
35	team of exceptional drug	1	0.30%
36	in the fields of	1	0.30%
37	of exceptional drug developers	1	0.30%
38	exceptional drug developers including	1	0.30%
39	kriya therapeutics team pipeline	1	0.30%
40	targets diabetes mash undisclosed	1	0.30%

#	URL	Whois	Check
1	https://www.linkedin.com/company/kriyatx/	Whois	linkedin.com
2	https://twitter.com/kriyatx?lang=en	Whois	twitter.com